Panel rejects FDA's wish to use antipsychotics in children

11/18/2008 | NYTimes.com

An advisory committee opted not to support the FDA in its acceptance of using two psychiatric drugs in children. The panel criticized agency regulations on prescribing Johnson & Johnson's Risperdal and Eli Lilly and Co.'s Zyprexa for children and called for more efforts to curb their growing use, particularly for off-label treatment of ADHD.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR